Postes actifs de Duane Burnett
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Aquinnah Pharmaceuticals, Inc.
 Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - | - |
Arkuda Therapeutics, Inc.
 Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arkuda Therapeutics, Inc. engages in development of medicines to improve the lives of patients with neurological diseases. It leverages insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. The company was founded by Gerhard Koenig and Duane Burnett in 2018 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 04/04/2023 | - |
| Fondateur | 01/01/2018 | - | |
| Corporate Officer/Principal | 01/01/2018 | 04/04/2023 |
Historique de carrière de Duane Burnett
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Arkuda Therapeutics, Inc.
Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arkuda Therapeutics, Inc. engages in development of medicines to improve the lives of patients with neurological diseases. It leverages insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. The company was founded by Gerhard Koenig and Duane Burnett in 2018 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Duane Burnett
- Expérience
